Edition:
United Kingdom

Aravive Inc (ARAV.OQ)

ARAV.OQ on NASDAQ Stock Exchange Global Select Market

7.37USD
8:00pm GMT
Change (% chg)

$-0.83 (-10.12%)
Prev Close
$8.20
Open
$8.20
Day's High
$8.20
Day's Low
$7.18
Volume
6,925
Avg. Vol
8,520
52-wk High
$15.15
52-wk Low
$3.07

Latest Key Developments (Source: Significant Developments)

Aravive Says Co May Offer Shares Of Common Stock Having Aggregate Offering Price Of Up To $20.25 Million
10:52am GMT 

March 26 (Reuters) - Aravive Inc ::ARAVIVE-MAY OFFER/ SELL SHARES OF COMMON STOCK HAVING AGGREGATE OFFERING PRICE OF UP TO $20.25 MILLION FROM TIME TO TIME THROUGH PIPER JAFFRAY-SEC FILING.  Full Article

Aravive Reports Fourth Quarter And Full Year 2018 Financial Results
Thursday, 7 Mar 2019 

March 7 (Reuters) - Aravive Inc ::ARAVIVE REPORTS FOURTH QUARTER AND FULL YEAR 2018 FINANCIAL RESULTS AND PROVIDES RECENT CORPORATE UPDATES.Q4 LOSS PER SHARE $4.82.CASH AND CASH EQUIVALENTS WERE $57.0 MILLION AS OF DECEMBER 31, 2018.EXPECTS CURRENT CASH AND CASH EQUIVALENTS WILL ENABLE COMPANY TO FUND ITS OPERATING PLANS INTO END OF 2020.QTRLY TOTAL REVENUE $1.4 MILLION VERSUS $40 MILLION.  Full Article

Aravive Presents Detailed Results Of Phase 1 Clinical Trial Of AVB-S6-500 At The 2018 EORTC-NCI-AACR Symposium
Tuesday, 13 Nov 2018 

Nov 13 (Reuters) - Aravive Inc ::ARAVIVE PRESENTS DETAILED RESULTS OF PHASE 1 CLINICAL TRIAL OF AVB-S6-500 AT THE 2018 EORTC-NCI-AACR SYMPOSIUM.ARAVIVE INC - PHASE 1 CLINICAL TRIAL IN HEALTHY VOLUNTEERS DEMONSTRATED THAT AVB-S6-500 WAS WELL TOLERATED WITH AN ACCEPTABLE SAFETY PROFILE..ARAVIVE INC - THERE WERE NO SERIOUS ADVERSE EVENTS (AES) AND AVB-S6-500 WAS WELL TOLERATED ACROSS ALL DOSES.  Full Article

Versartis Q1 Loss Per Share $0.25
Tuesday, 8 May 2018 

May 8 (Reuters) - Versartis Inc ::VERSARTIS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.25.CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS WERE $74.7 MILLION AS OF MARCH 31, 2018.  Full Article

Versartis reports Q3 loss $1.40/shr
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - Versartis Inc :Versartis reports third quarter 2017 financial results and provides corporate update.Q3 loss per share $1.40.Q3 earnings per share view $-0.71 -- Thomson Reuters I/B/E/S.  Full Article